No Result

View All Result

No products in the cart.

Home All Specialties Chronic Disease

#VisualAbstract: Neoadjuvant Nivolumab and Ipilimumab Improve Outcomes in Resectable Stage III Melanoma

byAstrid BradshawandMinjee Kim

June 18, 2024

in Chronic Disease, StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Neoadjuvant chemotherapy does not improve disease-free survival in patients with locally advanced colon cancer

The addition of a carboplatin to standard of care adjuvant chemotherapy improves survival outcomes in patients with high-risk, early-stage triple-negative breast cancer

Artificial intelligence matches dermatologists in melanoma diagnosis

#VisualAbstract: Patient Education Program May Reduce Disability and Symptoms of Chronic Pain

RelatedReports

Development of a risk index for colorectal cancer screening

Chronic Disease

Neoadjuvant chemotherapy does not improve disease-free survival in patients with locally advanced colon cancer

March 25, 2026

Age and breast cancer risk factors associated with false-positive mammography results

Chronic Disease

The addition of a carboplatin to standard of care adjuvant chemotherapy improves survival outcomes in patients with high-risk, early-stage triple-negative breast cancer

January 12, 2026

AI Roundup

Artificial intelligence matches dermatologists in melanoma diagnosis

September 15, 2025

AI Roundup

2MM: AI Roundup –Dermatology accuracy, faster drug discovery, heart disease detection, and global medical training [September 11th,  2025]

September 25, 2025

#VisualAbstract: Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Liver Fibrosis was More Effective Than Placebo at Resolving MASH

Early asthma and COPD intervention decreases healthcare utilization

The POET trial: oral antibiotics in stable endocarditis patients noninferior to intravenous treatment

Heat exposure associated with increased myocardial blood flow

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result